Jefferies Raises Revenue Expectations for Complete Genomics

Jefferies analyst Jon Wood also raised his price target on the firm's stock to $15.50 from $13, following a presentation by Complete Genomics CEO Clifford Reid at a biotech conference.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.